Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuri D'Alessandra

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
International Journal of Cardiology|February 15, 2012
Diagnostic potential of circulating miR-499-5p in elderly patients with acute non ST-elevation myocardial infarctionFabiola Olivieri, Roberto Antonicelli, Maria Lorenzi, et al.
Journal of Clinical Medicine|May 15, 2020
Circulating MicroRNAs as Potential Predictors of Anthracycline-Induced Troponin Elevation in Breast Cancer Patients: Diverging Effects of Doxorubicin and EpirubicinSonia Gioffré, Mattia Chiesa, Daniela Maria Cardinale, et al.
Cell Death & Disease|August 25, 2017
Doxorubicin upregulates CXCR4 via miR-200c/ZEB1-dependent mechanism in human cardiac mesenchymal progenitor cellsSara Beji, Giuseppina Milano, Alessandro Scopece, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 2, 2011
Human cord blood CD34+ progenitor cells acquire functional cardiac properties through a cell fusion processDaniele Avitabile, Alessia Crespi, Chiara Brioschi, et al.
European Heart Journal|June 11, 2010
Circulating microRNAs are new and sensitive biomarkers of myocardial infarctionYuri D'Alessandra, Paolo Devanna, Federica Limana, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|August 29, 2025
Angiogenic and reparative potency of a human cardiac CD90<sup>-</sup> mesenchymal subpopulation in heart ischemic modelElisa Gambini, Erica Rurali, Veronica Barbagallo, et al.
Scientific Reports|July 8, 2017
MiR-320a as a Potential Novel Circulating Biomarker of Arrhythmogenic CardioMyopathyElena Sommariva, Yuri D'Alessandra, Floriana Maria Farina, et al.
Cardiovascular Research|July 20, 2020
Cardiac dysfunction in cancer patients: beyond direct cardiomyocyte damage of anticancer drugs: novel cardio-oncology insights from the joint 2019 meeting of the ESC Working Groups of Myocardial Function and Cellular Biology of the HeartCarlo Gabriele Tocchetti, Pietro Ameri, Rudolf A de Boer, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
International Journal of Cardiology|February 15, 2012
Diagnostic potential of circulating miR-499-5p in elderly patients with acute non ST-elevation myocardial infarctionFabiola Olivieri, Roberto Antonicelli, Maria Lorenzi, et al.
Journal of Clinical Medicine|May 15, 2020
Circulating MicroRNAs as Potential Predictors of Anthracycline-Induced Troponin Elevation in Breast Cancer Patients: Diverging Effects of Doxorubicin and EpirubicinSonia Gioffré, Mattia Chiesa, Daniela Maria Cardinale, et al.
Cell Death & Disease|August 25, 2017
Doxorubicin upregulates CXCR4 via miR-200c/ZEB1-dependent mechanism in human cardiac mesenchymal progenitor cellsSara Beji, Giuseppina Milano, Alessandro Scopece, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 2, 2011
Human cord blood CD34+ progenitor cells acquire functional cardiac properties through a cell fusion processDaniele Avitabile, Alessia Crespi, Chiara Brioschi, et al.
European Heart Journal|June 11, 2010
Circulating microRNAs are new and sensitive biomarkers of myocardial infarctionYuri D'Alessandra, Paolo Devanna, Federica Limana, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|August 29, 2025
Angiogenic and reparative potency of a human cardiac CD90<sup>-</sup> mesenchymal subpopulation in heart ischemic modelElisa Gambini, Erica Rurali, Veronica Barbagallo, et al.
Scientific Reports|July 8, 2017
MiR-320a as a Potential Novel Circulating Biomarker of Arrhythmogenic CardioMyopathyElena Sommariva, Yuri D'Alessandra, Floriana Maria Farina, et al.
Cardiovascular Research|July 20, 2020
Cardiac dysfunction in cancer patients: beyond direct cardiomyocyte damage of anticancer drugs: novel cardio-oncology insights from the joint 2019 meeting of the ESC Working Groups of Myocardial Function and Cellular Biology of the HeartCarlo Gabriele Tocchetti, Pietro Ameri, Rudolf A de Boer, et al.
Pageof 4